Ultragenyx Pharmaceutical
RARE
#5525
Rank
$1.48 B
Marketcap
$15.03
Share price
-1.89%
Change (1 day)
-50.03%
Change (1 year)

P/S ratio for Ultragenyx Pharmaceutical (RARE)

P/S ratio as of October 2026 (TTM): 2.07

According to Ultragenyx Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -5.22. At the end of 2026 the company had a P/S ratio of 4.23.

P/S ratio history for Ultragenyx Pharmaceutical from 2014 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.2324.93%
20253.38-52.74%
20247.16-20.85%
20239.041.15%
20228.94-45.19%
202116.3-51.73%
202033.841.86%
201923.8-44.54%
201842.9-94.32%
2017756-96.5%
2016> 1000
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Lexicon Pharmaceuticals
LXRX
20.1 873.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
1.96-5.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 247.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.41 65.02%๐Ÿ‡บ๐Ÿ‡ธ USA